SCHEMBL3661213

SCHEMBL3661213

O=C(Nc1ccccc1O)c1ccc(O)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.74
MEN1 O00255 3/20 0.74
KMT2A Q03164 3/20 0.74
TP53 P04637 2/20 0.74
RAB9A P51151 2/20 0.74
LMNA P02545 1/20 0.61
GAA P10253 1/20 0.61
HTT P42858 1/20 0.61
TOP1 P11387 2/20 0.58
TERT O14746 1/20 0.58
AURKA O14965 1/20 0.55
POLB P06746 1/20 0.55
HDAC1 Q13547 1/20 0.55
TOP2A P11388 1/20 0.55
TOP2B Q02880 1/20 0.55
DEGS1 O15121 1/20 0.54
MMP1 P03956 1/20 0.54
MMP2 P08253 1/20 0.54
MMP9 P14780 1/20 0.54
METAP2 P50579 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6029925 0.94 NPC1 (0.82) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL1470784 0.88 NPC1 (0.73) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL4946074 0.88 NPC1 (0.73) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL308111 0.87 NPC1 (0.72) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL30608697 0.85 NPC1 (0.70) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL11523681 0.85 NPC1 (1.00) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL651227 0.85 NPC1 (0.70) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL16404286 0.85 NPC1 (0.70) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL16335223 0.85 MEN1 (0.79) NPC1MEN1KMT2ATP53RAB9A
SCHEMBL27619265 0.84 NPC1 (0.55) NPC1MEN1KMT2ATP53RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8175959-A None JP disclosed
JP-7330595-A None JP disclosed
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-2219600-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2010-08-25 EP disclosed
WO-2009067095-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. (US) 2009-05-28 WO disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
CN-1308297-C Phenyl sulfamate derivs. TEIKOKU HORMONE MFG CO LTD (JP) 2007-04-04 CN disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed
US-6762205-B1 STEROID SULFATASE INHIBITORS WITHOUT ESTROGENIC SIDE EFFECT ACTION TEIKOKU HORMONE MFG. CO., LTD. (JP) 2004-07-13 US disclosed
CN-1360570-A Phenyl sulfamate derivs. TEIKOKU HORMONE MFG CO LTD (JP) 2002-07-24 CN disclosed
EP-1193250-A1 PHENYL SULFAMATE DERIVATIVES Teikoku Hormone Mfg. Co., Ltd. (JP) 2002-04-03 EP disclosed
JP-H08175959-A SKIN COSMETIC KAO CORP 1996-07-09 JP disclosed
JP-H07330595-A SUPPRESSANT FOR CELL ADHESION KAO CORP 1995-12-19 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC NPC1 4845/4885MEN1 2813/4885KMT2A 998/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR NPC1 3666/4885MEN1 1028/4885KMT2A 847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.